168 related articles for article (PubMed ID: 30140485)
1. Analytical methods for investigating
Su C; Liu Y; He Y; Gu J
J Pharm Anal; 2018 Aug; 8(4):219-225. PubMed ID: 30140485
[TBL] [Abstract][Full Text] [Related]
2. PEGylated nanoliposomes encapsulating angiogenic peptides improve perfusion defects: Radionuclide imaging-based study.
Hwang H; Jeong HS; Oh PS; Kim M; Lee TK; Kwon J; Kim HS; Lim ST; Sohn MH; Jeong HJ
Nucl Med Biol; 2016 Sep; 43(9):552-558. PubMed ID: 27395415
[TBL] [Abstract][Full Text] [Related]
3. Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer.
Wei Y; Liang J; Zheng X; Pi C; Liu H; Yang H; Zou Y; Ye Y; Zhao L
Int J Nanomedicine; 2017; 12():251-261. PubMed ID: 28096670
[TBL] [Abstract][Full Text] [Related]
4. Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study.
Salem HF; Ahmed SM; Hassaballah AE; Omar MM
Drug Des Devel Ther; 2015; 9():3705-27. PubMed ID: 26229435
[TBL] [Abstract][Full Text] [Related]
5. Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide.
Re F; Cambianica I; Sesana S; Salvati E; Cagnotto A; Salmona M; Couraud PO; Moghimi SM; Masserini M; Sancini G
J Biotechnol; 2011 Dec; 156(4):341-6. PubMed ID: 21763360
[TBL] [Abstract][Full Text] [Related]
6. Cationic Nanoliposomes Are Efficiently Taken up by Alveolar Macrophages but Have Little Access to Dendritic Cells and Interstitial Macrophages in the Normal and CpG-Stimulated Lungs.
Vanbever R; Loira-Pastoriza C; Dauguet N; Hérin C; Ibouraadaten S; Vanvarenberg K; Ucakar B; Tyteca D; Huaux F
Mol Pharm; 2019 May; 16(5):2048-2059. PubMed ID: 30965005
[TBL] [Abstract][Full Text] [Related]
7. Ligand-functionalized nanoliposomes for targeted delivery of galantamine.
Mufamadi MS; Choonara YE; Kumar P; Modi G; Naidoo D; van Vuuren S; Ndesendo VM; Toit LC; Iyuke SE; Pillay V
Int J Pharm; 2013 May; 448(1):267-81. PubMed ID: 23535346
[TBL] [Abstract][Full Text] [Related]
8. Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes.
Zucker D; Barenholz Y
J Control Release; 2010 Sep; 146(3):326-33. PubMed ID: 20685223
[TBL] [Abstract][Full Text] [Related]
9. Investigation on Physicochemical Characteristics of a Nanoliposome-Based System for Dual Drug Delivery.
Nam JH; Kim SY; Seong H
Nanoscale Res Lett; 2018 Apr; 13(1):101. PubMed ID: 29654484
[TBL] [Abstract][Full Text] [Related]
10. Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy.
Zucker D; Andriyanov AV; Steiner A; Raviv U; Barenholz Y
J Control Release; 2012 Jun; 160(2):281-9. PubMed ID: 22019556
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity evaluation of anionic nanoliposomes and nanolipoplexes prepared by the heating method without employing volatile solvents and detergents.
Mozafari MR; Reed CJ; Rostron C
Pharmazie; 2007 Mar; 62(3):205-9. PubMed ID: 17416197
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characterizations of PEGylated liposomal doxorubicin.
Jiang W; Lionberger R; Yu LX
Bioanalysis; 2011 Feb; 3(3):333-44. PubMed ID: 21320053
[TBL] [Abstract][Full Text] [Related]
13. N-Oxy lipid-based click chemistry for orthogonal coupling of mannan onto nanoliposomes prepared by microfluidic mixing: Synthesis of lipids, characterisation of mannan-coated nanoliposomes and in vitro stimulation of dendritic cells.
Bartheldyová E; Turánek Knotigová P; Zachová K; Mašek J; Kulich P; Effenberg R; Zyka D; Hubatka F; Kotouček J; Čelechovská H; Héžová R; Tomečková A; Mašková E; Fojtíková M; Macaulay S; Bystrický P; Paulovičová L; Paulovičová E; Drož L; Ledvina M; Raška M; Turánek J
Carbohydr Polym; 2019 Mar; 207():521-532. PubMed ID: 30600036
[TBL] [Abstract][Full Text] [Related]
14. Nanoliposomes as Vehicles for Astaxanthin: Characterization, In Vitro Release Evaluation and Structure.
Pan L; Wang H; Gu K
Molecules; 2018 Oct; 23(11):. PubMed ID: 30380797
[TBL] [Abstract][Full Text] [Related]
15. Using liposomes to target infection and inflammation induced by foreign body injuries or medical implants.
Schroeder A; Turjeman K; Schroeder JE; Leibergall M; Barenholz Y
Expert Opin Drug Deliv; 2010 Oct; 7(10):1175-89. PubMed ID: 20858166
[TBL] [Abstract][Full Text] [Related]
16. Statistical fluctuation in zeta potential distribution of nanoliposomes measured by on-chip microcapillary electrophoresis.
Kato K; Koido M; Kobayashi M; Akagi T; Ichiki T
Electrophoresis; 2013 Apr; 34(8):1212-8. PubMed ID: 23401269
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of in vitro release behavior of proanthocyanidins flexible nanoliposomes and general nanoliposomes].
Chen Y; Wu H; Yuan J; Shi L; Jin R; Liu H; Xiong W; Huang L
Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(2):169-72. PubMed ID: 20394286
[TBL] [Abstract][Full Text] [Related]
18. In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice.
Jin M; Shen X; Zhao C; Qin X; Liu H; Huang L; Qiu Z; Liu Y
Drug Deliv; 2013; 20(3-4):127-33. PubMed ID: 23731485
[TBL] [Abstract][Full Text] [Related]
19. Medium-chain fatty acid nanoliposomes for easy energy supply.
Liu W; Liu WL; Liu CM; Liu JH; Yang SB; Zheng HJ; Lei HW; Ruan R; Li T; Tu ZC; Song XY
Nutrition; 2011 Jun; 27(6):700-6. PubMed ID: 20869208
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
